ProCE Banner Activity

Highlights From EASL 2019

Slideset Download
Conference Coverage
Expert faculty members summarize key studies on hepatitis C treatment and elimination, hepatitis B treatment, NASH/NAFLD clinical impact, and NASH treatment studies from this important annual conference.

Released: April 30, 2019

Expiration: April 28, 2020

No longer available for credit.

Share

Faculty

Nancy Reau

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Zobair M. Younossi

Zobair M. Younossi, MD, MPH, FACP, FACG

Executive Director, Center for Liver Diseases
Inova Fairfax Hospital
Executive Director of Research
Inova Health System
Professor of Medicine
Virginia Commonwealth University, Inova Campus
Annandale, Virginia

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

AbbVie

Gilead

Faculty Disclosure

Primary Author

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

Zobair M. Younossi, MD, MPH, FACP, FACG

Executive Director, Center for Liver Diseases
Inova Fairfax Hospital
Executive Director of Research
Inova Health System
Professor of Medicine
Virginia Commonwealth University, Inova Campus
Annandale, Virginia

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany